Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vidamed ceases TUNA physician training and pulls home page after receiving FDA warning letter on July 16.

This article was originally published in The Gray Sheet

Executive Summary

VIDAMED HALTS TUNA BPH SYSTEM PHYSICIAN TRAINING PROGRAM and withdraws the company's home page on the Internet in response to a July 16 FDA warning letter citing the firm for pre-approval promotion of the system. "Upon receipt of the [warning] letter, Vidamed removed its home page from the Internet and canceled all non-clinical investigator training workshops in the United States," Vidamed declared in a July 31 press release.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006480

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel